Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;32(1):3-16.
doi: 10.1007/s12022-021-09663-4. Epub 2021 Jan 12.

Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Sylvia L Asa  1   2 , Ozgur Mete  3   4 , Shereen Ezzat  5
Affiliations
Review

Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Sylvia L Asa et al. Endocr Pathol. 2021 Mar.

Abstract

Molecular pathology has advanced our understanding of many tumors and offers opportunities to identify novel therapies. In the pituitary, the field has uncovered several genetic mutations that predispose to pituitary neuroendocrine tumor (PitNET) development, including MEN1, CDKN1B, PRKRIα, AIP, GPR101, and other more rare events; however, these genes are only rarely mutated in sporadic PitNETs. Recurrent genetic events in sporadic PitNETs include GNAS mutations in a subset of somatotroph tumors and ubiquitin-specific peptidase mutations (e.g., USP8, USP48) in some corticotroph tumors; to date, neither of these has resulted in altered management, and instead, the prognosis and management of PitNETs still rely more on cell type and subtype as well as local growth that determines surgical resectability. In contrast, craniopharyngiomas have either CTNNB1 or BRAFV600E mutations that correlate with adamantinomatous or papillary morphology, respectively; the latter offers the opportunity for targeted therapy. DICER1 mutations are found in patients with pituitary blastoma. Epigenetic changes are implicated in the pathogenesis of the more common sporadic pituitary neoplasms including the majority of PitNETs and tumors of pituicytes.

Keywords: Craniopharyngioma; Epigenetics; Mutation; Pituicytoma; Pituitary blastoma; Pituitary neuroendocrine tumor.

PubMed Disclaimer

References

    1. Asa SL, Perry A. Tumors of the Pituitary Gland. Atlas of Tumor nd Nontumor Pathology, Series 5, Fascicle 1. Arlington VA: ARP Press, 2020.
    1. Asa SL, Penz G, Kovacs K, Ezrin C. Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis. Arch Pathol Lab Med 1982; 106:360–363.
    1. Horvath E, Lloyd RV, Kovacs K. Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells. A morphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest 1990; 63:511–520.
    1. Asa SL, Casar-Borota O, Chanson P et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 2017; 24(4):C5-C8. - PubMed
    1. Mete O, Lopes MB, Asa SL. Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol 2013; 37(11):1694-1699. - PubMed

LinkOut - more resources